This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
BP (BP), Royal Dutch Shell (RDSb), Tullow Oil (TLW) - Oil prices surged during the start of 2016 trading as relations between top crude producers Saudi Arabia and Iran deteriorated, raising concerns about potential supply disruptions. Closing price 354.00p,1543.00p,165.70p (Reuters)
Tesco (TSCO) - Tesco Plc's subsidiary in Turkey has decided to hang onto some of its stores instead of selling them to rival Turkish retailer Begendik after their performance improved strongly, it said on Saturday. Closing price 149.50p (Reuters)
Shire Pharmaceuticals (SHP) - Shire appears to be inching towards an agreement with Baxalta, the producer of specialist treatments for cancer and haemophilia, that the Dublin-based pharmaceuticals company has been trying to buy since last summer, The Times reported. Closing price 4698p. (Reuters)
Lloyds (LLOY) - Is set to become a fully privately owned company by the summer for the first time since its £20bn taxpayer-funded bailout as the UK sells its remaining 9 percent stake, The Times reported. Closing price 73.07p. (Reuters)
Hikma Pharmaceuticals (HIK) – Hikma has received the U.S. Food and Drug Administrator’s nod for its Neostigmine Methylsulfate injection. The company said it has launched the product in the U.S. market. Closing price 2301p (Reuters)
Rio Tinto (RIO.L), BHP Billiton (BLT.L) and Anglo American (AAL.L) - Chinese manufacturing contracted for a fifth straight month causing the CSI 300 Index to fall 7%. Closing Prices 1979.50p, 760.00p and 299.45p (Bloomberg)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research